Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Mepolizumab Treatment on Rhinovirus Induced Asthma Exacerbations

NCT01520051 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT01520051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01520051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Mepolizumab Treatment on Rhinovirus Induced Asthma Exacerbations
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2012
Completion date
March 31, 2014
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, viral infection